We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
Cap. Flow
+$1.28B
Cap. Flow %
3.53%
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$34.8M
2
AAPL icon
Apple
AAPL
+$33.7M
3
XOM icon
ExxonMobil
XOM
+$30M
4
MSFT icon
Microsoft
MSFT
+$25.3M
5
FTV icon
Fortive
FTV
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Financials 14.59%
3 Healthcare 13.89%
4 Industrials 10.54%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXF icon
2076
Fox Factory Holding Corp
FOXF
$785M
$619K ﹤0.01%
26,961
+6,275
+30% +$124K
WRLD icon
2077
World Acceptance Corp
WRLD
$838M
$619K ﹤0.01%
12,630
+135
+1% +$6.47K
RUTH
2078
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$617K ﹤0.01%
43,716
+3,910
+10% +$59.8K
GTT
2079
DELISTED
GTT Communications, Inc.
GTT
$617K ﹤0.01%
26,210
+260
+1% +$5.49K
OME
2080
DELISTED
Omega Protein
OME
$615K ﹤0.01%
26,330
+490
+2% +$11.5K
GKOS icon
2081
Glaukos
GKOS
$10.1B
$614K ﹤0.01%
16,268
+2,445
+18% +$80.9K
CHGG icon
2082
Chegg
CHGG
$114M
$613K ﹤0.01%
86,510
+750
+0.9% +$4.8K
AMRI
2083
DELISTED
Albany Molecular Research Inc
AMRI
$613K ﹤0.01%
37,114
+250
+0.7% +$3.7K
HRTX icon
2084
Heron Therapeutics
HRTX
$96.8M
$611K ﹤0.01%
35,466
+265
+0.8% +$4.92K
TOWR
2085
DELISTED
Tower International, Inc.
TOWR
$611K ﹤0.01%
25,341
+350
+1% +$8.03K
CTT
2086
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$609K ﹤0.01%
52,072
+1,500
+3% +$17.7K
HEES
2087
DELISTED
H&E Equipment Services
HEES
$608K ﹤0.01%
36,274
+410
+1% +$7.04K
LORL
2088
DELISTED
Loral Space and Communications, Inc.
LORL
$608K ﹤0.01%
15,552
-75
-0.5% -$2.71K
FOR icon
2089
Forestar Group
FOR
$1.47B
$607K ﹤0.01%
51,847
-405
-0.8% -$4.89K
NVAX icon
2090
Novavax
NVAX
$1.22B
$607K ﹤0.01%
14,585
+99
+0.7% +$12.8K
PKE icon
2091
Park Aerospace
PKE
$774M
$607K ﹤0.01%
34,957
+3,634
+12% +$59.2K
CIA icon
2092
Citizens
CIA
$236M
$605K ﹤0.01%
64,613
-850
-1% -$7.89K
SHOE
2093
Shoe Station Group
SHOE
$419M
$601K ﹤0.01%
45,108
+6,560
+17% +$88.2K
CLDX icon
2094
Celldex Therapeutics
CLDX
$2.96B
$598K ﹤0.01%
9,874
+500
+5% +$31.1K
SPOK icon
2095
Spok Holdings
SPOK
$232M
$597K ﹤0.01%
33,505
+1,055
+3% +$19K
CCF
2096
DELISTED
Chase Corporation
CCF
$597K ﹤0.01%
8,640
+325
+4% +$20.3K
UIS icon
2097
Unisys
UIS
$218M
$594K ﹤0.01%
60,999
+550
+0.9% +$5.11K
SHOR
2098
DELISTED
ShoreTel, Inc.
SHOR
$594K ﹤0.01%
74,284
+550
+0.7% +$4.3K
ATRA icon
2099
Atara Biotherapeutics
ATRA
$77M
$592K ﹤0.01%
1,106
+40
+4% +$21.7K
BPMC
2100
DELISTED
Blueprint Medicines
BPMC
$591K ﹤0.01%
19,911
+3,670
+23% +$91.2K

Similar funds

RhumbLine Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.

  • RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
  • RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
  • RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
  • RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
  • RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
  • RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.